Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s share price passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 208.38 ($2.71) and traded as low as GBX 161.28 ($2.09). Faron Pharmaceuticals Oy shares last traded at GBX 177.50 ($2.30), with a volume of 77,081 shares.
Faron Pharmaceuticals Oy Trading Up 2.5 %
The company has a quick ratio of 1.09, a current ratio of 1.45 and a debt-to-equity ratio of 922.55. The firm’s 50-day simple moving average is GBX 208.38 and its 200 day simple moving average is GBX 165.67. The stock has a market capitalization of £190.41 million, a P/E ratio of -554.69 and a beta of 0.36.
Faron Pharmaceuticals Oy Company Profile
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company’s lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation.
Recommended Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- Market Cap Calculator: How to Calculate Market Cap
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What is Put Option Volume?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to buy stock: A step-by-step guide for beginners
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.